ALXO
ALX Oncology Holdings Inc. Common Stock
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
ALX Oncology (ALXO) Stock: Buy, Sell, or Hold?
$1.10
-0.02 (-1.35%)
▼
5d:
-19.49%
30d:
+11.78%
90d:
-43.56%
Open in Live Scanner
70/30 Portfolio Builder
Earnings: Nov 06, 2026
0d
Protect ALXO Gains
Updated Nov 10, 12:00 AM ET
QUANTITATIVE VERDICT
WAIT
LOW Confidence (67%)
Quality Score
44/100
Position
SLIGHTLY LOW
30-Day Fair Range
$1.06 – $1.27
Position: SLIGHTLY LOW
Forward P/E & Valuation
-2.0x
Next 12M consensus est.
Wall Street Target
$4.60
+314.4% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$1.03 / $1.42
Trend: Strong Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: ALXO is down 19.5% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When ALXO Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: ALXO is currently trading at $1.09, which is considered slightly low relative to its 30-day fair value range of $1.06 to $1.27.
Technical Outlook: Technically, ALXO is in a strong downtrend. Immediate support is located at $1.03, while resistance sits at $1.42.
Market Sentiment: ALXO scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $4.60 (+314.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ALXO is in a strong downtrend. Immediate support is located at $1.03, while resistance sits at $1.42.
Market Sentiment: ALXO scores 20/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $4.60 (+314.4%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$1.06 -
$1.27
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
66.7%
Trading Range & Key Levels
30-Day Trading Range
$1.06 -
$1.27
Current vs Trading Range
SLIGHTLY LOW
Expected Move (7 Days)
±$0.26
(23.4%)
Support Level
$1.03
Resistance Level
$1.42
Current Trend
Strong Downtrend
Technical data as of
Nov 10, 2026
Protect Your Profits
Holding ALXO? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanQuantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Options cheap (IV 0th percentile)
- BEARISH: Weak technical setup (20/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 314.4% below Wall St target ($4.60)
- WARNING: Composite score 44/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-2.04
Wall Street Target
$4.60
(+314.4%)
Revenue Growth (YoY)
-100.0%
Share ALXO Analysis
Share this live ALXO analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (ALXO)
Bullish
1 Retail Mentions
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Nov 3, 2026
Daily AI digest
AI Retail Discussion Summary:
Investor $Bullish1 expresses optimism about $ALXO's potential in breast cancer trials with Jazz Pharmaceuticals' FDA-approved zanidatamab
Key Retail Themes:
Collaboration between ALXO and Jazz Pharmaceuticals
FDA approval of Jazz Pharmaceuticals' zanidatamab
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 9:52 AM ET
Data refreshes hourly during market hours. Next update: 10:52 AM
Data refreshes hourly during market hours. Next update: 10:52 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ALXO showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
IONS
Ionis Pharmaceuticals Inc |
STRONG BUY
25 analysts |
$84 | 45 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
APLS
Apellis Pharmaceuticals … |
BUY
22 analysts |
$41 | 50 HOLD |
|
GPCR
Structure Therapeutics I… |
STRONG BUY
16 analysts |
$107 | 49 HOLD |
|
ABVX
Abivax SA American Depos… |
STRONG BUY
12 analysts |
$164 | 62 BUY |
Advanced ALXO Option Strategies
Professional options setups generated by AI based on today's ALXO price and gamma walls.
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive ALXO Research Pages
